Equities

DIH Holding US Inc

DHAI:NMQ

DIH Holding US Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.59
  • Today's Change0.00 / 0.00%
  • Shares traded25.58k
  • 1 Year change-84.86%
  • Beta--
Data delayed at least 15 minutes, as of May 22 2024 16:26 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

DIH Holding US, Inc. is a global robotics and virtual reality (VR) technology provider in the rehabilitation and human performance industry. The Company offers an integrated solution for the entire continuum of care and multiple markets, including hospitals, clinics, research and home. Its rehabilitation hospitals and outpatient clinics offering solutions include ArmeoPower, ArmeoSpring, ArmeoSpring Pro, ArmeoSenso, Erigo, Lokomat, SafeGait 360 by Gorbel, RYSEN, Andago, C-Mill, and HocoNet. Its Research & Academia offering solutions include GRAIL, CAREN Extended, M-Gait, and D-Flow. The ArmeoSpring Pro is a cutting-edge medical device designed to bring upper limb rehabilitation to the next level. ArmeoPower guides the initial phases of arm and hand function recovery. ArmeoSpring supports the recovery of arm and hand functions. ArmeoSenso is a sensor-based solution for arm function recovery. HocoNet is a software platform connecting product portfolio across the entire continuum of care.

  • Revenue in USD (TTM)60.30m
  • Net income in USD-1.77m
  • Incorporated2024
  • Employees--
  • Location
    DIH Holding US Inc4 Embarcadero Center, Suite 1449SAN FRANCISCO 94105United StatesUSA
  • Phone+1 (614) 365-0143
  • Fax+1 (302) 655-5049
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Apyx Medical Corp50.45m-22.81m55.43m252.00--2.74--1.10-0.6583-0.65831.460.58460.79141.774.49200,202.40-35.94-25.24-46.73-29.9763.7066.11-45.41-46.004.94-9.210.6207--17.6125.8219.28--7.99--
Alpha Pro Tech, Ltd.60.92m4.21m57.51m124.0013.680.907711.190.94410.35960.35965.225.420.89081.688.21491,250.006.1615.216.3316.0638.1940.236.9212.9315.31--0.000.00-1.215.6027.642.935.50--
InspireMD Inc6.48m-22.69m58.09m65.00--1.55--8.97-0.7594-0.75940.21081.500.20912.344.9799,646.16-73.26-60.59-86.14-72.9726.6520.46-350.35-334.787.41--0.00--20.0011.50-7.71--41.57--
Medinotec Inc3.05m-566.90k58.67m29.00--28.27--19.24-0.0483-0.04830.25980.17690.67122.0616.96105,130.70-12.48---13.23--53.56---18.59--8.571.440.4323---3.91---184.47------
Beyond Air Inc689.00k-66.70m59.21m98.00--2.20--85.93-2.13-2.130.02190.58670.0111.441.247,030.61-112.64-70.88-148.49-88.69-115.24---10,288.68-1,530.313.26--0.382-------29.27------
Envoy Medical Inc297.00k-22.43m59.78m34.00------201.28-2.21-2.210.0194-0.37820.04940.47372.368,735.29-381.38---2,885.46---118.18---7,718.86--0.8969-16.54----33.33---87.83------
Milestone Scientific Inc9.48m-7.06m60.62m17.00--8.06--6.40-0.0948-0.09480.12650.09740.80250.775612.04557,570.60-60.13-55.48-80.86-74.7269.4263.97-74.93-88.941.80--0.0011--11.600.423320.41---7.99--
Heartbeam Inc0.00-15.11m62.40m15.00--4.98-----0.6111-0.61110.000.47620.00----0.00-200.17---258.74--------------0.00-------12.94------
Monogram Technologies Inc365.00k-13.39m63.02m28.00------172.67-0.4414-0.44140.012--0.0316----13,035.71-115.81-119.26-226.52-257.400.00---3,669.37-5,045.60----0.00-------0.3964---15.97--
Hyperfine Inc11.69m-41.93m63.90m131.00--0.8448--5.47-0.5858-0.58580.16331.050.11271.032.8089,251.91-40.40---43.95--42.39---358.59--8.26--0.00--61.90--39.54------
DIH Holding US Inc60.30m-1.77m64.47m--------1.07-0.0435-0.04351.49-0.8079----------------60.18---2.93--0.26561.50----12.15--80.41------
Pro-Dex Inc48.24m5.00m65.49m146.0013.772.1310.831.361.391.3913.448.980.97462.303.68330,438.3010.1115.4312.9418.8728.2533.1510.3714.922.16--0.27530.009.6215.4654.7232.380.8422--
Vivos Inc18.00k-3.20m66.13m10.00--49.29--3,673.92-0.0087-0.00870.000050.00340.0127--3.13---225.38-202.25-235.64-552.77-33.3310.79-17,805.45-11,969.07----0.00---46.58---17.19------
Asensus Surgical Inc8.72m-78.71m67.54m207.00--5.18--7.74-0.3065-0.30650.03390.04790.12711.7913.0942,144.93-114.63-71.10-146.89-79.04-52.04-71.39-902.25-1,207.710.689--0.00--21.02-18.67-3.80---6.14--
Neuronetics Inc73.23m-27.54m73.19m202.00--2.64--0.9996-0.9484-0.94842.520.92260.70612.265.43360,714.30-26.56-28.02-30.98-34.7375.5275.73-37.61-51.045.18-4.270.6825--9.426.2218.76--18.57--
Data as of May 22 2024. Currency figures normalised to DIH Holding US Inc's reporting currency: US Dollar USD

Institutional shareholders

1.06%Per cent of shares held by top holders
HolderShares% Held
Polar Asset Management Partners, Inc.as of 31 Mar 2024297.50k0.73%
Tuttle Capital Management LLCas of 31 Mar 202444.00k0.11%
Yakira Capital Management, Inc.as of 31 Mar 202426.96k0.07%
Geode Capital Management LLCas of 31 Mar 202416.48k0.04%
Parkwood LLCas of 31 Mar 202415.00k0.04%
Bluefin Capital Management LLCas of 31 Mar 202413.61k0.03%
XTX Markets LLCas of 31 Mar 202410.35k0.03%
Mint Tower Capital BVas of 31 Mar 20247.50k0.02%
UBS Securities LLCas of 31 Mar 20249.000.00%
JPMorgan Securities LLC (Investment Management)as of 31 Mar 20246.000.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.